Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)

BACKGROUND: In the phase II ATTRACTION-1 study, nivolumab demonstrated a promising antitumor activity among Japanese patients with treatment-refractory advanced esophageal cancer. Here, we report the follow-up results of ATTRACTION-1 of > 5 years. METHODS: We enrolled patients with esophageal can...

Descripción completa

Detalles Bibliográficos
Autores principales: Satoh, Taroh, Kato, Ken, Ura, Takashi, Hamamoto, Yasuo, Kojima, Takashi, Tsushima, Takahiro, Hironaka, Shuichi, Hara, Hiroki, Iwasa, Satoru, Muro, Kei, Yasui, Hirofumi, Minashi, Keiko, Yamaguchi, Kensei, Ohtsu, Atsushi, Doki, Yuichiro, Matsumura, Yasuhiro, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387268/
https://www.ncbi.nlm.nih.gov/pubmed/33993388
http://dx.doi.org/10.1007/s10388-021-00850-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387268/
https://www.ncbi.nlm.nih.gov/pubmed/33993388
http://dx.doi.org/10.1007/s10388-021-00850-0

Ejemplares similares